Business Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI. Read the original report. Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Articles You May Like Sports betting is increasingly the norm for Gen Z. Here’s why some financial and mental health experts are worried Boomers’ dividend stocks take beating from bond yields, with retirement income on the line Traders now see little chance of a Fed rate hike in October after weak jobs report Up to 25 million Trump Accounts could be funded by mid-October, IRS CEO Frank Bisignano says Berkshire buys more Lennar shares, but pace of purchases slows